These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 22913327)
1. Clinical use of differential nuclear medicine modalities in patients with ATTR amyloidosis. Noordzij W; Glaudemans AW; Slart RH; Dierckx RA; Hazenberg BP Amyloid; 2012 Dec; 19(4):208-11. PubMed ID: 22913327 [TBL] [Abstract][Full Text] [Related]
2. Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis. Stats MA; Stone JR Cardiovasc Pathol; 2016; 25(5):413-7. PubMed ID: 27469499 [TBL] [Abstract][Full Text] [Related]
3. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive risk stratification of patients with transthyretin amyloidosis. Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252 [TBL] [Abstract][Full Text] [Related]
6. Nuclear imaging in cardiac amyloidosis. Glaudemans AW; Slart RH; Zeebregts CJ; Veltman NC; Tio RA; Hazenberg BP; Dierckx RA Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):702-14. PubMed ID: 19156411 [TBL] [Abstract][Full Text] [Related]
7. The Utility of Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403 [TBL] [Abstract][Full Text] [Related]
8. Cases from a busy nuclear cardiology laboratory: Potential pitfalls in the interpretation of cardiac scintigraphy for ATTR cardiac amyloidosis. Wehbe RM; Kansal P; Holly TA J Nucl Cardiol; 2021 Apr; 28(2):653-660. PubMed ID: 32383085 [TBL] [Abstract][Full Text] [Related]
9. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study. Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579 [TBL] [Abstract][Full Text] [Related]
10. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy. Minutoli F; Di Bella G; Mazzeo A; Donato R; Russo M; Scribano E; Baldari S AJR Am J Roentgenol; 2013 Mar; 200(3):W256-65. PubMed ID: 23436870 [TBL] [Abstract][Full Text] [Related]
12. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945 [TBL] [Abstract][Full Text] [Related]
13. 99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications. Lee J; Kim K; Choi JO; Kim SJ; Jeon ES; Choi JY Medicine (Baltimore); 2020 Jan; 99(4):e18905. PubMed ID: 31977903 [TBL] [Abstract][Full Text] [Related]
14. Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature. Frantellizzi V; Cosma L; Pani A; Pontico M; Conte M; De Angelis C; De Vincentis G Curr Med Imaging; 2020; 16(8):957-966. PubMed ID: 33081658 [TBL] [Abstract][Full Text] [Related]
15. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. Antoni G; Lubberink M; Estrada S; Axelsson J; Carlson K; Lindsjö L; Kero T; Långström B; Granstam SO; Rosengren S; Vedin O; Wassberg C; Wikström G; Westermark P; Sörensen J J Nucl Med; 2013 Feb; 54(2):213-20. PubMed ID: 23238792 [TBL] [Abstract][Full Text] [Related]
17. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902 [TBL] [Abstract][Full Text] [Related]
18. Bone scintigraphy for early detection of transthyretin cardiac amyloidosis. Ikram A J Pak Med Assoc; 2016 Aug; 66(8):1045. PubMed ID: 27524550 [No Abstract] [Full Text] [Related]
19. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis. Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207 [TBL] [Abstract][Full Text] [Related]
20. The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis. Cohen OC; Sharpley F; Gilbertson JA; Wechalekar AD; Sachchithanantham S; Mahmood S; Whelan CJ; Martinez-Naharro A; Fontana M; Lachmann HJ; Hawkins PN; Gillmore JD Eur J Haematol; 2020 Sep; 105(3):352-356. PubMed ID: 32495369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]